Glenmede Trust’s USA Compression Partners USAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$353K Hold
13,100
﹤0.01% 1022
2024
Q4
$309K Hold
13,100
﹤0.01% 1093
2024
Q3
$300K Hold
13,100
﹤0.01% 1094
2024
Q2
$311K Hold
13,100
﹤0.01% 1047
2024
Q1
$349K Buy
13,100
+4,100
+46% +$104K ﹤0.01% 1016
2023
Q4
$205K Sell
9,000
-7,500
-45% -$186K ﹤0.01% 1144
2023
Q3
$394K Hold
16,500
﹤0.01% 913
2023
Q2
$349K Hold
16,500
﹤0.01% 938
2023
Q1
$349K Sell
16,500
-8,000
-33% -$165K ﹤0.01% 943
2022
Q4
$478K Hold
24,500
﹤0.01% 843
2022
Q3
$426K Buy
24,500
+2,732
+13% +$48.3K ﹤0.01% 846
2022
Q2
$363K Buy
+21,768
New +$391K ﹤0.01% 949

Other funds holding USAC

Glenmede Trust's USAC Position: Q1 2025 in Review

Glenmede Trust held its USA Compression Partners (USAC) position steady in Q1 2025 at 13,100 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #1022.

Glenmede Trust first reported a position in USAC in Q2 2022 and has held it in 12 quarters since. The position peaked at $478K in Q4 2022. 102 funds tracked by Wall St. Rank hold USAC as of Q1 2025.

  • Glenmede Trust held 13,100 shares of USA Compression Partners worth $353K as of Q1 2025.
  • Glenmede Trust left its USA Compression Partners share count unchanged in Q1 2025.
  • USA Compression Partners made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2025, its #1022 holding.
  • Glenmede Trust first reported a position in USA Compression Partners in Q2 2022 and has held it in 12 quarters since.
  • Glenmede Trust's USA Compression Partners position peaked at $478K in Q4 2022.
  • 102 funds tracked by Wall St. Rank held USA Compression Partners as of Q1 2025.

Based on Glenmede Trust's 13F filing for Q1 2025, filed 15 May 2025.